Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
01/07/1998 | EP0815851A2 Method of reducing irritativeness of surface active agents and aqueous compositions with reduced irritativeness |
01/07/1998 | EP0815846A1 Ultrafine oil-in-water emulsion containing a crosslinked at least 90% neutralized polymer of 2-acrylamide-2-methylpropane sulfonic acid and method of preparation |
01/07/1998 | EP0815844A1 Topical surfactant-free oil-in-water emulsion containing a crosslinked neutralized polymer of 2-acrylamide-2-methylpropane sulfonic acid |
01/07/1998 | EP0815829A1 Use of amino-alcohol derivatives containing an urea function in cosmetic and dermatologic compositions |
01/07/1998 | EP0815212A1 Novel encapsulation process by a gelling polymer |
01/07/1998 | EP0814899A1 Composition for stabilizing a suspension and pharmaceutical uses of said composition and of said suspension |
01/07/1998 | EP0814844A2 Thyroxine/cyclodextrin complexes and pharmaceutical compositions containing the same |
01/07/1998 | EP0814841A2 Hcg liquid formulations |
01/07/1998 | EP0814840A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent |
01/07/1998 | EP0814839A1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid |
01/07/1998 | EP0814837A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
01/07/1998 | EP0814835A1 Method for enhancing immunogenicity, product obtained and pharmaceutical composition |
01/07/1998 | EP0814828A1 Method of preparation a therapeutic agent for the regeneration of oligodendrocytes |
01/07/1998 | EP0814824A1 Effervescent composition with dry extract of ginkgo biloba |
01/07/1998 | EP0814823A1 Polyphenol fractions of tea, the use thereof and formulations containing them |
01/07/1998 | EP0814815A1 Poly(hydroxy acid)/polymer conjugates for skin applications |
01/07/1998 | EP0814811A1 Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women |
01/07/1998 | EP0814805A1 Process and products for reducing biological fluid levels of a lipid soluble waste |
01/07/1998 | EP0814800A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
01/07/1998 | EP0814797A1 Parenteral pharmaceutical compositions containing ammoniumalkyl salts of 2-arylpropionic acids |
01/07/1998 | EP0814794A1 Lidocaine-vasoconstrictor aerosol preparation |
01/07/1998 | EP0814793A1 Prilocaine and hydrofluorocarbon aerosol preparations |
01/07/1998 | EP0814790A1 Nasal and ocular administration of ketamine to manage pain and for detoxification |
01/07/1998 | EP0814789A1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
01/07/1998 | EP0814787A1 Oil in water emulsions containing propofol and edetate |
01/07/1998 | EP0814784A1 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
01/07/1998 | EP0814783A1 Multiple unit effervescent dosage forms comprising protonpump inhibitor |
01/07/1998 | EP0814782A1 Pharmaceutical composition stabilized with a basic agent |
01/07/1998 | EP0814781A1 Long-shelf-life medicaments |
01/07/1998 | EP0814780A1 Diltiazem controlled release formulation |
01/07/1998 | EP0814779A1 Novel encapsulation compositions and methods |
01/07/1998 | EP0814778A1 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
01/07/1998 | EP0814777A1 Stable lipid-comprising drug delivery complexes and methods for their production |
01/07/1998 | EP0814776A1 Topically applied pharmaceutical composition, method of preparing it and its use |
01/07/1998 | EP0814775A1 Method and kit for preventing erectile dysfunction |
01/07/1998 | EP0814774A1 Reduction of adhesions using controlled delivery of active oxygen inhibitors |
01/07/1998 | EP0814773A1 Pectin liquid pharmaceutical compositions |
01/07/1998 | EP0814772A1 Pectin pharmaceutical compositions |
01/07/1998 | EP0814771A1 Improvements in or relating to organic compositions |
01/07/1998 | EP0814770A1 Process for the preparation of a solid pharmaceutical dosage form |
01/07/1998 | EP0814769A1 Aerosolized general anesthetic agents |
01/07/1998 | EP0814766A1 Cosmetic and/or pharmaceutical preparations |
01/07/1998 | EP0814756A1 Method for preparing a preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders |
01/07/1998 | EP0814753A2 Cosmetic or dermatological gels based on microemulsions |
01/07/1998 | EP0814752A2 Cosmetic or pharmaceutical microemulsions |
01/07/1998 | EP0814751A1 Coolant compositions |
01/07/1998 | EP0814675A1 Cholesterol lowering food product containing dietary fiber encapsulated in zein |
01/07/1998 | EP0814670A1 Method for production of chewing or bubble gum and chewing or bubble gum |
01/07/1998 | EP0814660A1 Topical antimicrobial agents |
01/07/1998 | EP0787044A4 Polymerized phospholipid membrane mediated synthesis of metal nanoparticles |
01/07/1998 | EP0764047A4 Polymeric microbeads and method of preparation |
01/07/1998 | EP0759162A4 Structures with field responsive permeation control |
01/07/1998 | EP0717761A4 Water-soluble pressure-sensitive mucoadhesive and devices provided therewith for emplacement in a mucosa-lined body cavity |
01/07/1998 | EP0633766B1 Moisturizer |
01/07/1998 | EP0546158B1 Capsule extrusion systems |
01/07/1998 | EP0539442B1 Enzyme inactivators |
01/07/1998 | EP0427741B1 Subsaturated transdermal delivery device |
01/07/1998 | CN2271897Y Hemostatic and antiphlogistic venous fixation plaster |
01/07/1998 | CN1169676A Oral pharmaceutical formulation containing magnesium salt of omeprazole |
01/07/1998 | CN1169315A Immunity-regulating health-care tea |
01/07/1998 | CN1169309A Compounded Chinese medicinal preparation containing ginseng and American ginseng and preparation method thereof |
01/07/1998 | CN1169304A Pill made from eight Chinese medicinal herbs and production technology thereof |
01/07/1998 | CN1169302A 一种面尔康膏 A surface Kang cream |
01/07/1998 | CN1169301A Compounded |
01/07/1998 | CN1169291A External application powder composition and cloth-wetting agent |
01/07/1998 | CN1169283A 多孔性胶囊 Porous capsules |
01/07/1998 | CN1036923C Use of dehydrated trehalose as drying agent |
01/06/1998 | US5705693 Cationic lipids |
01/06/1998 | US5705655 Compounds used to produce liposomes useful as carriers for delivering macromolecules intracellularly |
01/06/1998 | US5705606 Polypeptides for binding aggregation mediators such as fibrogen |
01/06/1998 | US5705510 Use of cabergoline and related ergoline derivatives for controlling intraocular pressure |
01/06/1998 | US5705506 Pharmaceutical compositions of alkylsulphonamides 5HT1 agonists for rectal administration |
01/06/1998 | US5705485 Gel formulations containing growth factors |
01/06/1998 | US5705482 Human growth hormone and leucine-histidine-leucine tripeptide mixture; storage stability; glandular disorders |
01/06/1998 | US5705385 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
01/06/1998 | US5705270 Microcapsules prepared from crosslinkable polysaccharides, polycations and/or lipids and use therefor |
01/06/1998 | US5705197 Extraction process for producing PLGA microspheres |
01/06/1998 | US5705196 Applications in biomedicine, pharmacy, medicine, cosmetics, chemical industry, agriculture, veterinary medicine |
01/06/1998 | US5705195 Drug delivery into blood for cardiovascular disorders |
01/06/1998 | US5705194 Bioavailability, nose, mouth, eyes |
01/06/1998 | US5705192 Fluidized beds and spraying then removal of solvent and forming tablets |
01/06/1998 | US5705191 Sustained delivery of active compounds from tubules, with rational control |
01/06/1998 | US5705190 Comprising water soluble alginate, complex salt of alginic acid, and organic carboxylic acid; with clarithromycin |
01/06/1998 | US5705189 Thermoplastic material for drug coatings which dissolve in intestinal juices |
01/06/1998 | US5705188 Lipid mixture, antitumor agents |
01/06/1998 | US5705187 Compositions of lipids and stabilizing materials |
01/06/1998 | US5705186 Pharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide |
01/06/1998 | US5705185 Prevention degradation of estradiol during permeation |
01/06/1998 | US5705184 Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
01/06/1998 | US5705183 Cotton candy coated medication and a method for making and administering the same |
01/06/1998 | US5705180 Therapeutic agent for the treatment of melanomas |
01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
01/06/1998 | US5705175 Block polymers |
01/06/1998 | US5705168 Lactic acid for skin disorders |
01/06/1998 | US5705158 Kits with antileukocyte antibody conjugates |
01/06/1998 | US5704910 Implantable device and use therefor |
01/06/1998 | US5704297 Dry powder composition of hydroxyethyl starch suitable for reconstitution |
01/06/1998 | CA2084875C Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use |
01/02/1998 | DE19627340A1 Arzneimittel Drug |
01/02/1998 | DE19624426A1 Magnetic particle for transport of diagnostic or therapeutic agent |